leadf
logo-loader
viewMMJ Group Holdings Ltd

MMJ Group well-placed to capitalise on continuing cannabis opportunities

The company's investment strategy is focused on opportunities in new businesses in the global cannabis market.

MMJ Group Holdings Ltd - MMJ Group  focused on investment strategy for 2020
The company is well placed to continue to roll-out its investment strategy

MMJ Group Holdings Ltd (ASX:MMJ) (OTCMKTS:MMJJF) believes that the current market and industry sentiment surrounding cannabis companies create investment opportunities in Canada and other countries at attractive valuations and prices.

In its annual report, the company was particularly upbeat about opportunities to invest in listed and unlisted cannabis businesses in Canada and it was well-placed to do so.

Chairman Peter Wall said that FY20 had seen the company implement its investment strategy to recycle capital raised from the sale of MediPharm Labs in 2018/19 into investment opportunities provided by existing and new investees.

New investments

He said: “Significant new investments included existing investees Weed Me Inc and Embark Health Inc, whilst we also added new investees in WeedMD Inc, Sequoya Cannabis Limited and Bespoke A Limited Partnership.

“MMJ’s asset manager, Embark Ventures Inc (EbV), has added considerable value in sourcing new investments to diversify our cannabis portfolio whilst also providing resources to actively manage MMJ’s holdings in existing investments.”

MMJ also holds warrants, which are similar to options in Australia, and contractual rights in a number of its existing listed and unlisted investments which provide opportunities to make follow-on investments in businesses at a discount to future valuations and where it is well placed to understand their potential returns.

SPP supports investments

In February 2020, MMJ announced a share purchase plan (SPP) with the company receiving eligible subscriptions of A$389,400 from 158 shareholders at the issue price of 8 cents per share.

Those MMJ shareholders who supported the company’s SPP through subscribing for new shares have been rewarded with share price appreciation.

The funds raised were invested in a follow-on investment in Sequoya.

Robust financials

Notably, the impact of the coronavirus (COVID-19) pandemic up to June 30, 2020, has not had a financial impact on MMJ.

Wall said: “The internal operations of MMJ have not been significantly impacted and we have not observed a material adverse impact on the operations of our material investments or any consequential material specific impact from COVID-19 on MMJ’s valuation, and/or any impact on recoverability of loans advanced during the year still receivable as at 30 June 2020.”

Material changes during the period in the fair value of investees include:

  • Revaluation gain of A$5.4 million from investment in Embark based on the price of its latest material capital raising;
  • Devaluation of A$1.5 million from investment in Weed Me following assessment of fair value based on MMJ assessment of fair value;
  • Realised loss of A$3.6 million from residual investment in MediPharm Labs, however, MMJ has made a total return of A$25.3 million on its investment since acquisition; and
  • Loss of A$2.8 million on investment in WeedMD based on decline in listed value of securities.

Strategy looking forwards

MMJ is confident it is well placed to continue to roll-out its investment strategy for the remainder of 2020 and into 2021.

Key elements of the strategy are:

  • For MMJ’s asset manager, EbV, to work with MMJ’s investees to understand their respective funding requirements and add value to the existing portfolio; and
  • To make further investments at currently depressed valuations in Canadian cannabis stocks which will materially add value to the portfolio during the next 12 months.

Wall said the board appreciated the continued support of MMJ’s shareholders during a challenging period in its efforts to generate positive returns for shareholders.

He said: “We remain committed to delivering value for all shareholders.”

Quick facts: MMJ Group Holdings Ltd

Price: 0.105 AUD

ASX:MMJ
Market: ASX
Market Cap: $24.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MMJ Group Holdings Ltd named herein, including the promotion by the Company of MMJ Group Holdings Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Full interview: MMJ Group sees strong future for cannabis sector amid global...

MMJ Group (ASX: MMJ) Non-Executive Director Michael Curtis joined Steve Darling from Proactive Vancouver to discuss his thoughts on the cannabis industry and how that sector is doing during the Corona outbreak. Cannabis stores were deemed an essential service. Curtis also talked about how...

on 13/5/20

3 min read